E. Ohman J:or Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

E. Ohman J:or Asset Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-6,600	Closed	-$890K	–	450
2022 Q3	$890K	Hold	6,600	–	–	0.04%	246
2022 Q2	$1.07M	Sell	6,600 -2,400	-27%	-$375K	0.05%	224
2022 Q1	$1.7M	Hold	9,000	–	–	0.06%	197
2021 Q4	$2.44M	Hold	9,000	–	–	0.07%	166
2021 Q3	$3.27M	Hold	9,000	–	–	0.1%	113
2021 Q2	$3.09M	Buy	9,000 +800	+10%	+$265K	0.1%	129
2021 Q1	$2.85M	Buy	8,200 +800	+11%	+$265K	0.1%	120
2020 Q4	$1.91M	Buy	+7,400	New	+$2.04M	0.08%	140

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

E. Ohman J:or Asset Management's ONC Position: Q4 2022 in Review

E. Ohman J:or Asset Management sold out of BeOne Medicines Ltd (ONC) in Q4 2022, closing a stake of 6,600 shares — an estimated $890K sold.

E. Ohman J:or Asset Management first reported a position in ONC in Q4 2020 and held it in 8 quarters. The position peaked at $3.27M in Q3 2021. 212 funds tracked by Wall St. Rank hold ONC as of Q4 2022.

E. Ohman J:or Asset Management reported no remaining BeOne Medicines Ltd position as of Q4 2022 after selling out during the quarter.
E. Ohman J:or Asset Management sold 6,600 BeOne Medicines Ltd shares in Q4 2022, an estimated $890K.
E. Ohman J:or Asset Management first reported a position in BeOne Medicines Ltd in Q4 2020 and held it in 8 quarters.
E. Ohman J:or Asset Management's BeOne Medicines Ltd position peaked at $3.27M in Q3 2021.
212 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2022.

Based on E. Ohman J:or Asset Management's 13F filing for Q4 2022, filed 5 Apr 2024.